ArticleBritish journal of cancer2022

miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome.

Maria-Alexandra Papadimitriou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.